Oruka Therapeutics, Inc.
ORKA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,277 | -$24,574 | -$20,999 | -$25,781 |
| Dep. & Amort. | $20 | $19 | $16 | $16 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5,077 | $0 | $0 |
| Change in WC | $1,965 | -$2,289 | -$3,034 | $3,980 |
| Other Non-Cash | $6,690 | -$1,378 | $3,148 | $2,967 |
| Operating Cash Flow | -$21,602 | -$23,145 | -$20,869 | -$18,818 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$99 | -$34 | -$13 | -$18 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$107,999 | -$44,290 | $0 |
| Inv. Sales/Matur. | $0 | $112,893 | $87,169 | $0 |
| Other Inv. Act. | -$122,350 | $0 | $0 | -$329,938 |
| Investing Cash Flow | -$122,449 | $4,860 | $42,866 | -$329,956 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $109 | $0 | $29,394 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $169,908 | $0 | $0 | -$29,920 |
| Financing Cash Flow | $169,908 | $109 | $0 | -$526 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $25,857 | -$18,176 | $21,997 | -$349,300 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65,396 | $83,572 | $61,575 | $410,875 |
| End Cash | $91,253 | $65,396 | $83,572 | $61,575 |
| Free Cash Flow | -$21,701 | -$23,179 | -$20,882 | -$18,836 |